Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors.

Three series of novel imidazoline derivatives were designed, synthesized, and evaluated for their p53-MDM2 binding inhibitory activities, and anti-proliferation activities against PC3, A549, KB, and HCT116 cancer cell lines. Five of the tested compounds showed enhanced p53-MDM2 binding inhibitory potency and anti-proliferation activities in comparison with that of Nutlin-1. Flow cytometric analysis indicated that compound 7c, one of the most potent p53-MDM2 binding inhibitors with a K(i) value of 0.6 μM, showed its ability to arrest cell cycle progression.

[1]  A. Fersht,et al.  Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.

[2]  Ling He,et al.  Lithium chloride-catalyzed selective demethylation of aryl methyl ethers under microwave irradiation , 2007 .

[3]  N. Zefirov,et al.  Reaction of Aromatic Aldehydes with Ammonium Acetate , 2002 .

[4]  Su Qiu,et al.  Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. , 2006, Journal of medicinal chemistry.

[5]  A. Moumen,et al.  A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation , 2011, BMC Cancer.

[6]  T. McDonnell,et al.  The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death , 2009, Apoptosis.

[7]  Small molecule inhibitors of the p53-MDM2. , 2008, Current medicinal chemistry.

[8]  G. Sal,et al.  p53-family proteins and their regulators: hubs and spokes in tumor suppression , 2010, Cell Death and Differentiation.

[9]  Heather A Carlson,et al.  Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models. , 2007, Journal of the American Chemical Society.

[10]  M. Protopopova,et al.  Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors , 2004, Nature Medicine.

[11]  Per Källblad,et al.  Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. , 2005, Bioorganic & medicinal chemistry letters.

[12]  D. Lane,et al.  Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets? , 2004, Trends in pharmacological sciences.

[13]  Maxwell D Cummings,et al.  1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR. , 2005, Bioorganic & medicinal chemistry letters.

[14]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[15]  Y. Kita,et al.  One-pot synthesis of imidazolines from aldehydes: detailed study about solvents and substrates , 2007 .